MINNEAPOLIS--(BUSINESS WIRE)--Urologix®, Inc. (NASDAQ:ULGX), today reported financial results for the fiscal 2009 third quarter ended March 31, 2009. Revenue for the third quarter was $3.3 million or 8 percent more than the $3.1 million reported in the same period of fiscal 2008, however it was 2 percent less than the $3.4 million reported in the second quarter of fiscal year 2009.
